Nanobiotix SA (NBTX)
4.24
+0.03
(+0.79%)
USD |
NASDAQ |
Jun 21, 16:00
4.22
-0.02
(-0.47%)
After-Hours: 20:00
Nanobiotix Total Liabilities (Quarterly): 105.83M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 105.83M |
| June 30, 2023 | 102.36M |
| June 30, 2023 | 102.36M |
| December 31, 2022 | 93.10M |
| June 30, 2022 | 82.35M |
| June 30, 2022 | 82.35M |
| December 31, 2021 | 84.89M |
| June 30, 2021 | 98.16M |
| June 30, 2021 | 98.16M |
| December 31, 2020 | 78.18M |
| June 30, 2020 | 75.31M |
| June 30, 2020 | 75.31M |
| December 31, 2019 | 65.10M |
| June 30, 2019 | 62.05M |
| June 30, 2019 | 62.05M |
| December 31, 2018 | 36.55M |
| Date | Value |
|---|---|
| June 30, 2018 | 13.38M |
| June 30, 2018 | 13.38M |
| December 31, 2017 | 16.25M |
| June 30, 2017 | 13.09M |
| June 30, 2017 | 13.09M |
| December 31, 2016 | 13.75M |
| June 30, 2016 | 10.71M |
| June 30, 2016 | 10.71M |
| December 31, 2015 | 11.82M |
| June 30, 2015 | 9.974M |
| June 30, 2015 | 9.974M |
| December 31, 2014 | 8.194M |
| June 30, 2014 | 6.048M |
| June 30, 2014 | 6.048M |
| December 31, 2013 | 5.878M |
| December 31, 2012 | 4.401M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
62.05M
Minimum
Jun 2019
105.83M
Maximum
Dec 2023
84.50M
Average
82.35M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| DBV Technologies SA | 34.24M |
| Cellectis SA | 263.89M |
| Genfit SA | 117.09M |
| Innate Pharma SA | 146.24M |
| Inventiva SA | 112.30M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 103.79M |
| Shareholders Equity (Quarterly) | -2.038M |
| Debt to Equity Ratio | -24.67 |
| Current Ratio | 1.751 |
| Net Debt Paydown Yield | -0.91% |